| Descriptor English: | Showdomycin | ||||
| Descriptor Spanish: |
Showdomicina
| ||||
| Descriptor Portuguese: | Showdomicina | ||||
| Descriptor French: | Showdomycine | ||||
| Tree number(s): |
D13.570.800.810 |
||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D012787 | ||||
| Scope note: | 3-beta-D-Ribofuranosylmaleimide. Antineoplastic antibiotic isolated from Streptomyces showdoensis. It is possibly active also as a sulfhydryl reagent. |
||||
| Annotation: | an antineoplastic antibiotic |
||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
| Pharm Action: |
Antibiotics, Antineoplastic Sulfhydryl Reagents |
||||
| Registry Number: | E1V8315QHY | ||||
| CAS Type 1 Name: | 1H-Pyrrole-2,5-dione, 3-beta-D-ribofuranosyl- | ||||
| Previous Indexing: |
Antibiotics, Antineoplastic (1971-1974) Maleimides (1974) Ribonucleosides (1973-1974) |
||||
| Public MeSH Note: | 91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90 |
||||
| History Note: | 91(75); was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90 |
||||
| DeCS ID: | 23458 | ||||
| Unique ID: | D012787 | ||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
| Date Established: | 1991/01/01 | ||||
| Date of Entry: | 1974/11/19 | ||||
| Revision Date: | 2013/07/08 |
|
|
Showdomycin
- Preferred
| Concept UI |
M0019804 |
| Scope note | 3-beta-D-Ribofuranosylmaleimide. Antineoplastic antibiotic isolated from Streptomyces showdoensis. It is possibly active also as a sulfhydryl reagent. |
| Preferred term | Showdomycin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
